Will we ever eat lab-grown meat? Infant industry faces technical hurdles and fickle consumers

science labgrownmeat ss
Credit: Science Source

Blood, sweat and tears are a given, but we’ll also need to see significant movement in the price and availability of key raw materials before the [cell-based meat] industry can produce truly meaningful quantities of meat cost-effectively, said KC Carswell, PhD, VP process development at cell-cultured meat startup Memphis Meats, during a keynote speech at [the October 19] virtual Cultured Meat Symposium.

“To convince our customers and investors that we’re a viable industry, we have to be able to show a clear path to profit at scale,” said Dr Carswell.

To provide some context of the scale of the challenge, she said, “In the US alone we produce approximately 100bn lbs a year of beef, pork and poultry.

“Even the total global biopharma cell-culture capacity is a drop in the bucket when it comes to the scale of food.”

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

As for consumer acceptance, “It doesn’t matter how efficient or cost-effective our technologies are, or how smoothly the regulatory path functions if nobody’s interested in the products,” she noted.

However, she claimed, research suggests that “roughly two-thirds of US consumers would eat cell-based meat and many of those consumers are planning on eating it regularly… Massive segments of the population in countries throughout the world are hungry for cell-based meat.”

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.